Brivaracetam (CAS 357336-20-0): An Advanced Antiepileptic Compound for Seizure Control
High-affinity SV2A ligand for effective epilepsy management, offering a competitive edge in pharmaceutical research.
Get a Quote & SampleProduct Core Value
Brivaracetam
Brivaracetam (CAS 357336-20-0) is a cutting-edge pharmaceutical active ingredient known for its potent antiepileptic properties. It functions as a selective, high-affinity ligand for synaptic vesicle glycoprotein 2A (SV2A), a crucial target in neurological therapies. This compound is instrumental in controlling partial-onset seizures and demonstrates high purity, often exceeding 99%, making it a preferred choice for pharmaceutical development and research.
- Explore the use of Brivaracetam for seizure control in complex neurological cases, ensuring patient well-being.
- Discover the advantages of a high purity Brivaracetam supplier for critical pharmaceutical applications.
- Understand the mechanism of action for antiepileptic compounds like Brivaracetam as SV2A ligands.
- Investigate the competitive pricing of Brivaracetam pharmaceutical intermediates for your drug development pipeline.
Product Advantages
Enhanced Efficacy
Brivaracetam exhibits significantly higher affinity for SV2A compared to other related compounds, leading to potentially more effective seizure management and improved patient outcomes. This makes it a valuable tool in the development of novel antiepileptic treatments.
High Purity Standard
With an assay of over 99%, this pharmaceutical intermediate ensures reliability and consistency in research and manufacturing processes, crucial for meeting stringent quality demands in the pharmaceutical industry.
Competitive Pricing
Accessing high-quality pharmaceutical intermediates like Brivaracetam at competitive prices allows research institutions and manufacturers to optimize their R&D budgets and accelerate product development cycles.
Key Applications
Pharmaceutical Research
Utilized as a key component in the research and development of new antiepileptic drugs and neurological treatments, leveraging its unique SV2A ligand properties.
Epilepsy Treatment
Serves as an active pharmaceutical ingredient (API) for the formulation of medications aimed at controlling partial-onset seizures, improving the quality of life for patients.
Biochemical Studies
Employed in biochemical assays and studies to understand neurotransmitter release mechanisms and synaptic function, contributing to fundamental neuroscience research.
Custom Synthesis
Available for customized synthesis projects, providing flexibility for specialized research needs and the development of novel chemical entities.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).